Estrogen receptors (ERα/ERβ) in normal and pathological growth of the human myometrium: pregnancy and leiomyoma
article
OA: closed
CC0
⤵ 12 in-corpus citations
Abstract
The distributions of the mRNAs for estrogen receptors (ERalpha and ERbeta) and their binding properties in myometria of pregnant and nonpregnant women and in leiomyoma were studied. RT-PCR analysis indicated that the term pregnancy myometria had little ERalpha mRNA, whereas the amounts of ERbeta mRNAs in pregnant or nonpregnant myometria appeared to be similar. Both ERalpha and ERbeta mRNA were greater in certain leiomyoma than in normal nonpregnant myometria. The binding kinetics revealed that two specific binding sites (with high or low affinity) for 17beta-estradiol were present in the nonpregnant myometrium. Only the low-affinity binding sites were detectable in late-pregnancy myometria and in leiomyoma, and their capacities were increased two- to threefold (P < 0.001) in leiomyoma. The pregnancy- and leiomyoma-related changes in myometrial ER status, especially the low concentration of ERalpha mRNA and the lack of high-affinity ER in pregnant women, plus the increased ERalpha and ERbeta mRNAs and the increased low-affinity ER in some leiomyoma, suggest that the redistribution of ER subtypes is associated with the pathological and/or normal growth of the myometrium.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (40)
- Comparative Messenger Ribonucleic Acid Analysis of Immediate Early Genes and Sex Steroid Receptors in Human Leiomyoma and Healthy Myometrium via openalex
- Myometrial estradiol and progesterone receptor changes in preterm and term pregnancies via openalex
- W1542467604 via openalex
- W1590890179 via openalex
- W1602709607 via openalex
- W1966361420 via openalex
- W1966739722 via openalex
- W1969969891 via openalex
- W1978215499 via openalex
- W1979903836 via openalex
- W1981306061 via openalex
- W1985549816 via openalex
- W2001810755 via openalex
- W2003237625 via openalex
- W2008724101 via openalex
- W2020725121 via openalex
- W2021062790 via openalex
- W2029628645 via openalex
- W2034215598 via openalex
- W2047744045 via openalex
- W2055412146 via openalex
- W2055612412 via openalex
- W2063205034 via openalex
- W2066962102 via openalex
- W2070907292 via openalex
- W2073353512 via openalex
- W2073883348 via openalex
- W2087970188 via openalex
- W2088587953 via openalex
- W2102352943 via openalex
- W2121625670 via openalex
- W2134812217 via openalex
- W2161623422 via openalex
- W2163840069 via openalex
- W2266912790 via openalex
- W2914153261 via openalex
- W4212936275 via openalex
- W1234520200 via openalex
- W4294216491 via openalex
- W1492357441 via openalex
Cited by (12)
- A CLINICOPATHOLOGICAL STUDY OF UTERINE LEIOMYOMA IN WOMEN ABOVE 30 YEARS IN A TERTIARY CARE HOSPITAL OF ASSAM 2022
- Does prior uterine surgery increase the risks of uterine leiomyoma and adenomyosis? a retrospective study 2022
- Elinzanetant (NT-814), a Neurokinin 1,3 Receptor Antagonist, Reduces Estradiol and Progesterone in Healthy Women 2021
- Role of Hormones in Common Benign Uterine Lesions: Endometrial Polyps, Leiomyomas, and Adenomyosis 2020
- Isoliquiritigenin Suppresses E2-Induced Uterine Leiomyoma Growth through the Modulation of Cell Death Program and the Repression of ECM Accumulation 2019
- Coexistence of adenomyosis, adenocarcinoma, endometrial and myometrial lesions in resected uterine specimens 2018
- Comparative systems genetics view of endometriosis and uterine leiomyoma: Two sides of the same coin? 2016
- Uterine Fibroids: Pathogenesis and Interactions with Endometrium and Endomyometrial Junction 2013
- The association between heavy metals, endometriosis and uterine myomas among premenopausal women: National Health and Nutrition Examination Survey 1999-2002 2008
- Benign Gynecological Diseases and SERMs 2006
- GnRH analogs for the treatment of symptomatic uterine leiomyomas 2005
- Different expression of estrogen receptors α and β in human myometrium and leiomyoma during the proliferative phase of the menstrual cycle and after GnRHa treatment 2001
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK